Strides Pharma Science Limited (NSE:STAR)
India · Delayed Price · Currency is INR 1,030.00
-42.80 (-3.99%)
Jul 31, 2026, 3:30 PM IST
Strides Pharma Science Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 50,044 | 48,587 | 45,653 | 38,901 | 36,884 | 30,703 |
Revenue Growth | 8.07% | 6.43% | 17.36% | 5.47% | 20.13% | -7.41% |
Gross Profit Gross Profit Growth | 28,118 | 27,170 | 24,369 | 19,793 | 19,304 | 14,566 |
Operating Income Operating Income Growth | 6,539 | 6,497 | 6,093 | 3,609 | 1,439 | -2,373 |
Net Income Net Income Growth | 6,135 | 5,562 | 35,935 | -706.12 | -2,026 | -4,602 |
Earnings Per Share EPS Growth | 66.55 | 60.34 | 390.50 | -7.76 | -22.50 | -51.28 |
EPS Growth | 79.37% | -84.55% | - | - | - | - |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
North America North America Growth | 24,890 | 24,506 | 20,671 | 19,261 | 12,059 |
Australia Australia Growth | 5,082 | 4,396 | 3,651 | 3,116 | 3,175 |
Africa Africa Growth | 5,517 | 4,616 | 3,800 | 4,506 | 5,707 |
Europe Europe Growth | 10,265 | 9,938 | 8,663 | 8,370 | 6,769 |
India India Growth | 173.72 | 159.56 | 234.3 | 218.63 | 473.47 |
Asia (Excluding India) Asia (Excluding India) Growth | 173.57 | 225.46 | 164.67 | 460.56 | 1,971 |
Others Others Growth | 176.93 | 76.43 | 116.12 | 143.94 | 66.78 |
Unallocated Unallocated Growth | 2,307 | 1,737 | 1,601 | 807.18 | 481.94 |
Total Total Growth | 48,587 | 45,653 | 38,901 | 36,884 | 30,703 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,045 | 2,045 | 1,986 | 2,896 | 3,607 | 1,842 |
Total Debt Total Debt Growth | 17,580 | 17,580 | 18,796 | 25,169 | 30,296 | 30,250 |
Net Cash (Debt) Net Cash Growth | -15,535 | -15,535 | -16,810 | -22,273 | -26,689 | -28,408 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -168.52 | -168.54 | -182.68 | -244.75 | -296.27 | -316.54 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 7,025 | 6,844 | 7,011 | 444.11 | -2,578 |
Capital Expenditures CapEx Growth | - | -4,179 | -2,475 | -1,182 | -949.38 | -1,434 |
Free Cash Flow Free Cash Flow Growth | - | 2,846 | 4,369 | 5,829 | -505.27 | -4,012 |
Free Cash Flow Growth | - | -34.86% | -25.05% | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 56.19% | 55.92% | 53.38% | 50.88% | 52.34% | 47.44% |
Operating Margin | 13.07% | 13.37% | 13.35% | 9.28% | 3.90% | -7.73% |
Pretax Margin | 14.91% | 13.76% | 10.67% | -2.95% | -7.76% | -21.25% |
Profit Margin | 12.26% | 11.45% | 78.71% | -1.81% | -5.49% | -14.99% |
FCF Margin | - | 5.86% | 9.57% | 14.98% | -1.37% | -13.07% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 4.000 | 2.500 | 1.500 |
Dividend Per Share Growth | 25.00% | 25.00% | 60.00% | 66.67% | - |
Dividend Yield | 0.49% | 0.54% | 0.60% | 0.82% | 1.35% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 15.40 | 15.54 | 1.72 | - | - | - |
Forward PE | 13.67 | 13.68 | 13.18 | 26.97 | 22.79 | 72.99 |
P/FCF Ratio | 33.20 | 30.37 | 14.12 | 12.37 | - | - |
PS Ratio | 1.89 | 1.78 | 1.35 | 1.85 | 0.70 | 1.01 |